The BAD Investment Company Launches Flagship ETF
22 Décembre 2021 - 3:02PM
Business Wire
The large cap fund is designed to offer
exposure to companies operating in the betting, alcohol and drug
(pharmaceutical) industries.
The BAD Investment Company is pleased to announce the launch of
the BAD ETF (NYSE: BAD). The indexed, large cap fund is designed to
offer investors equally-weighted exposure to the B.A.D. market
segments – betting (casinos, gaming, and online gaming operations);
alcohol/cannabis (alcoholic beverage manufacturing and distribution
and/or cannabis cultivation and sales); and drugs (pharmaceutical
and biotechnology product development and manufacturing) – by
providing investment results that closely track the performance,
before fees and expenses, of the EQM BAD Index (BADIDX).
While the idea for creating funds focused on vice stocks is not
new, The BAD Investment Company saw a new opportunity to form a
fund around B.A.D. market segments specifically due to the nature
of how companies in these market segments are often treated – We
believe the vice industry exhibits defensive characteristics
(people often continue to do BAD things regardless of economic
conditions), yet are often “shunned”, and underinvested segments of
the market which has historically provided diversification
benefits, economic resilience, and competitive risk-adjusted
returns.
The BAD ETF also represents an intriguing alternative for a new
wave of retail investors who may be frustrated with aspects of the
ESG movement.
“With the proliferation of whitewashed ESG products and market
sub-segments like sports betting and cannabis becoming more widely
accepted socially and legally, we saw an opportunity to fill what
we perceived as a gap in the marketplace. We came to that
conclusion primarily by listening and watching this newly energized
retail crowd over the past year,” says Tommy Mancuso, president and
co-founder of The BAD Investment Company. “We believe they want
investment products rooted in transparency and quality that they
may also be able to understand and relate to as consumers whether
that is in health, wellbeing, or entertainment.”
The BAD Investment Company is embracing these changing trends to
not only create a product that is diversified across multiple vice
sectors but also offer investors exposure to long-term growth
opportunities. Mancuso added, “Many new or retail investors may
have a misconception and a ‘to the moon’ mentality when it comes to
investing and as exciting as that may sound, we believe should
focus on long-term investing and sustainable areas of the market
that have historically demonstrated to be profitable and withstood
multiple economic cycles.”
“Our mission is to position ourselves in a unique manner
compared to most fund management companies. It’s our opinion that
we don’t think or dress like the typical ‘suit,’ but are fully
capable of harnessing the expertise and insights of Wall Street to
provide strategically designed investment products.”
The BAD ETF is now trading on the NYSE (NYSE: BAD).
For more information on the BAD ETF, please visit
www.badinvestmentco.com.
About The BAD Investment
Company The BAD Investment Company is a registered
investment adviser and ETF sponsor. We focus on identifying themes
and sectors of the market that may appeal to investors as a
consumer and offer them long-term, sustainable investment
opportunities. To learn more about the company, please visit
badinvestmentco.com.
Disclaimer
Before investing carefully consider the fund’s investment
objective, risks, charges, and expenses. This and other information
are contained in the prospectus which can be obtained by visiting
www.badinvestmentco.com. Please read the prospectus carefully
before investing.
The Fund is a recently organized investment company with no
operating history. As a result, prospective investors have no track
record or history on which to base their investment decision.
Alcohol, betting, pharmaceutical, and cannabis companies are
subject to numerous risks. These industries face intense
competition including from participants performing illegal
activities or unregulated companies. Betting, Pharmaceutical and
Cannabis companies are particularly affected by increasing
regulatory constraints and the costs of complying with such
constraints.
Alcohol companies in particularly are subject to
demographic and product trends, changing consumer preferences,
nutritional and health-related concerns, competitive pricing,
marketing campaigns, and environmental factors.
The pharmaceutical companies can be significantly
affected by government approval of products and services,
government regulation and reimbursement rates, pricing pressure
(including price discounting), limited product lines, pricing
pressure (including price discounting), limited product lines,
patent expirations, and intense competition. The costs associated
with developing new drugs can be significant, and the results are
unpredictable.
Cannabis-related companies are subject to various laws
and regulations that may differ at the state/local and federal
level. These laws and regulations may (i) significantly affect a
cannabis-related company’s ability to secure financing, (ii) impact
the market for marijuana industry sales and services, and (iii) set
limitations on marijuana use, production, transportation, and
storage. In addition, cannabis-related companies are subject to the
risks associated with the greater agricultural industry, including
changes to or trends that affect commodity prices, labor costs,
weather conditions, and laws and regulations related to
environmental protection, health and safety.
Distributor: Foreside Fund Services, LLC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211222005089/en/
Ally Boyle For: The BAD Investment Company Ph: 267-614-4076
Bad ETF (AMEX:BAD)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Bad ETF (AMEX:BAD)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024